Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 35, Issue 5, Pages 419–429
http://dx.doi.org/10.1155/2013/139895
Research Article

Early Time-Dependent Dynamic Changes of TBET and GATA3 mRNA Expressions in Patients with Acute Coronary Syndrome

1Accident and Emergency Medicine Academic Unit, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong
2Department of Chemical Pathology, Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong
3Division of Cardiology, Department of Medicine & Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong

Received 26 June 2013; Revised 6 August 2013; Accepted 17 August 2013

Academic Editor: Francisco Blanco-Vaca

Copyright © 2013 Timothy H. Rainer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. W.-P. Zheng and R. A. Flavell, “The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells,” Cell, vol. 89, no. 4, pp. 587–596, 1997. View at Google Scholar · View at Scopus
  2. S. J. Szabo, S. T. Kim, G. L. Costa, X. Zhang, C. G. Fathman, and L. H. Glimcher, “A novel transcription factor, T-bet, directs Th1 lineage commitment,” Cell, vol. 100, no. 6, pp. 655–669, 2000. View at Google Scholar · View at Scopus
  3. K. M. Murphy and S. L. Reiner, “The lineage decisions of helper T cells,” Nature Reviews Immunology, vol. 2, no. 12, pp. 933–944, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. S. J. Szabo, B. M. Sullivan, S. L. Peng, and L. H. Glimcher, “Molecular mechanisms regulating Th1 immune responses,” Annual Review of Immunology, vol. 21, pp. 713–758, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Laurat, B. Poirier, E. Tupin et al., “In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice,” Circulation, vol. 104, no. 2, pp. 197–202, 2001. View at Google Scholar · View at Scopus
  6. H. Methe, S. Brunner, D. Wiegand, M. Nabauer, J. Koglin, and E. R. Edelman, “Enhanced T-helper-1 lymphocyte activation patterns in acute coronary syndromes,” Journal of the American College of Cardiology, vol. 45, no. 12, pp. 1939–1945, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Fisher and E. Folland, “Acute ischemic coronary artery disease and ischemic stroke: similarities and differences,” American Journal of Therapeutics, vol. 15, no. 2, pp. 137–149, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. Q.-W. Ji, M. Guo, J.-S. Zheng et al., “Downregulation of T helper cell type 3 in patients with acute coronary syndrome,” Archives of Medical Research, vol. 40, no. 4, pp. 285–293, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Soejima, A. Irie, S. Miyamoto et al., “Preference toward a T-helper type 1 response in patients with coronary spastic angina,” Circulation, vol. 107, no. 17, pp. 2196–2200, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. G. B. Sajan, T. Z. Qiu, X. Wang, and H.-P. Guo, “T helper cell related interleukins and the angiographic morphology in unstable angina,” Cytokine, vol. 30, no. 5, pp. 303–310, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Yamashita, K. Shimada, E. Seki, H. Mokuno, and H. Daida, “Concentrations of interleukins, interferon, and C-reactive protein in stable and unstable angina pectoris,” American Journal of Cardiology, vol. 91, no. 2, pp. 133–136, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. X. Cheng, Y.-H. Liao, H. Ge et al., “Th1/Th2 functional imbalance after acute myocardial infarction: coronary arterial inflammation or myocardial inflammation,” Journal of Clinical Immunology, vol. 25, no. 3, pp. 246–253, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Adler, Y. Levy, A. Roth, D. Wexler, G. Keren, and J. George, “Functional T-lymphocyte dichotomy in the peripheral blood of patients with unstable angina,” International Journal of Cardiovascular Interventions, vol. 7, no. 3, pp. 146–151, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. T. H. Rainer, R. W. Y. Chan, C. A. Graham et al., “Circulating leukocyte TBET and GATA3 mRNA in patients with acute coronary syndrome,” International Journal of Cardiology, vol. 156, no. 2, pp. 209–211, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. J. L. Anderson, C. D. Adams, E. M. Antman et al., “ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine,” Journal of the American College of Cardiology, vol. 50, no. 7, pp. e1–e157, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Thygesen, J. S. Alpert, and H. D. White, “Joint ESC/ACCF/AHA/WHF task force for the redefinition of myocardial infarction. Universal definition of myocardial infarction2007,” Journal of the American College of Cardiology, vol. 50, pp. 2173–2195, 2007. View at Google Scholar
  17. E. M. Antman, D. T. Anbe, P. W. Armstrong et al., “ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction),” Circulation, vol. 110, no. 9, pp. e82–e292, 2004. View at Google Scholar · View at Scopus
  18. G. W. Snedecor and W. G. Cochran, Statistical Methods, The Iowa State University Press, Ames, Iowa, USA, 6th edition, 1971.
  19. G. K. Hansson, “Immune mechanisms in atherosclerosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 21, pp. 1876–1890, 2001. View at Google Scholar
  20. P. Libby, “Current concepts of the pathogenesis of the acute coronary syndromes,” Circulation, vol. 104, no. 3, pp. 365–372, 2001. View at Google Scholar · View at Scopus
  21. G. J. Blake and P. M. Ridker, “Novel clinical markers of vascular wall inflammation,” Circulation Research, vol. 89, no. 9, pp. 763–771, 2001. View at Google Scholar · View at Scopus
  22. L. Lind, “Circulating markers of inflammation and atherosclerosis,” Atherosclerosis, vol. 169, no. 2, pp. 203–214, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. L. M. Biasucci, “CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: application to Clinical and Public Health Practice: clinical use of inflammatory markers in patients with cardiovascular diseases: a background paper,” Circulation, vol. 110, no. 25, pp. e560–e567, 2004. View at Google Scholar · View at Scopus
  24. S. J. Szabo, B. M. Sullivan, C. Sternmann, A. R. Satoskar, B. P. Sleckman, and L. H. Glimcher, “Distinct effects of T-bet in Th1 lineage commitment and IFN-γ production in CD4 and CD8 T cells,” Science, vol. 295, no. 5553, pp. 338–342, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. P. R. Moreno, E. Falk, I. F. Palacios, J. B. Newell, V. Fuster, and J. T. Fallon, “Macrophage infiltration in acute coronary syndromes: implications for plaque rupture,” Circulation, vol. 90, no. 2, pp. 775–778, 1994. View at Google Scholar · View at Scopus
  26. E. Lantelme, S. Mantovani, B. Palermo, R. Campanelli, F. Sallusto, and C. Giachino, “Kinetics of GATA-3 gene expression in early polarizing and committed human T cells,” Immunology, vol. 102, no. 2, pp. 123–130, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. H. J. Lee, N. Takemoto, H. Kurata et al., “GATA-3 induces T helper cell type 2 (Th2) cytokine expression and chromatin remodeling in committed Th1 cells,” Journal of Experimental Medicine, vol. 192, no. 1, pp. 105–115, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. J. L. Fernandes, R. L. Mamoni, J. L. Orford et al., “Increased Th1 activity in patients with coronary artery disease,” Cytokine, vol. 26, no. 3, pp. 131–137, 2004. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Chakir, H. Wang, D. E. Lefebvre, J. Webb, and F. W. Scott, “T-bet/GATA-3 ratio as a measure of the Th1/Th2 cytokine profile in mixed cell populations: Predominant role of GATA-3,” Journal of Immunological Methods, vol. 278, no. 1-2, pp. 157–169, 2003. View at Publisher · View at Google Scholar · View at Scopus